Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions

Immune checkpoint inhibitors (ICIs) have demonstrated marked clinical effects worldwide, and “cancer immunotherapy” has been recognized as a feasible option for cancer treatment. Significant treatment responses have already been attained for malignant melanoma and lung cancer, ahead of gynecologic c...

Full description

Bibliographic Details
Main Authors: Masahiro Kagabu, Takayuki Nagasawa, Chie Sato, Yasuko Fukagawa, Hanae Kawamura, Hidetoshi Tomabechi, Shuji Takemoto, Tadahiro Shoji, Tsukasa Baba
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:International Journal of Molecular Sciences
Subjects:
cervical cancer
immunotherapy
immune checkpoint inhibitor
chemoradiotherapy
Online Access:https://www.mdpi.com/1422-0067/21/7/2335

Internet

https://www.mdpi.com/1422-0067/21/7/2335

Similar Items